Budapest, Hungary

Tamas Szucs


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1980-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tamas Szucs: Innovator in Anti-Allergic Compounds

Introduction

Tamas Szucs is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-allergic compounds. With a total of 2 patents to his name, Szucs continues to push the boundaries of innovation in his area of expertise.

Latest Patents

His latest patents include groundbreaking work on nitrogen bridgehead compounds that exhibit anti-allergic effects. These compounds are described by specific formulas, including pharmaceutically acceptable salts, hydrates, stereoisomers, optically active isomers, geometrical isomers, or tautomeric forms. One of the most significant examples is the 9-phenylhydrazono-6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidine-3-carboxylic acid, which showcases the potential of these compounds in treating allergies and asthma.

Career Highlights

Tamas Szucs is currently associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company. His work there has been instrumental in advancing the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Szucs has collaborated with talented individuals such as Istvan Hermecz and Zoltan Meszaros. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Tamas Szucs stands out as a dedicated inventor whose work in anti-allergic compounds has the potential to make a significant impact in the pharmaceutical industry. His innovative spirit and collaborative efforts continue to drive advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…